Advertisement

Topics

Search Results for "Graves Disease And Agent Orange "

09:08 EDT 30th August 2016 | BioPortfolio

Matching Channels

Graves' disease

Congenital Graves' disease

Eye disease

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

p38 mitogen activated protein kinase MAPK Inhibitors

The next generation of p38 mitogen-activated protein kinase (MAPK) inhibitors has reached clinical proof-of-concept studies in phase II in a broad range of indications. While the previous generation o...

Matching News

Final review of health problems that may be linked to Agent Orange exposure during Vietnam War

The latest and final in a series of congressionally mandated biennial reviews of the evidence of health problems that may be linked to exposure to Agent Orange and other herbicides used during the Vie...

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking, according to recent findings in a larg...

Immunosuppressive therapy may reduce relapse risk in Graves’ disease

The addition of immunosuppressive drugs to the standard treatment of Graves’ disease may reduce the risk for relapse, according to study data. Tristan Mirko Struja, MD, of the department of medicine...

Agent Orange Linked to Bladder Cancer, Thyroid Problems, Panel Says

THURSDAY, March 10, 2016 -- There is stronger evidence of a link between the herbicide Agent Orange and bladder cancer and thyroid problems among U.S. military personnel exposed to the chemical during...

Treatment Options in the Young Patient With Graves' Disease

In this review, the advantages and disadvantages of available treatment options for young patients with Graves disease are discussed. Clinical Endocrinology

Managing Neonates Born to Mothers With Graves' Disease

A new literature-based algorithm provides guidance for physicians on managing neonates born to mothers with Graves' disease (GD). Reuters Health Information

Interprofessional education good for health care, optometry, patients

Just the other day a long-term patient presented with acute onset diplopia. While her demographic profile and clinical findings were consistent with a subtle ischemic sixth nerve palsy, my differentia...

NRDC plays scary Agent Orange card about 2,4-D herbicide found safe by regulators

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. There has been a long-running scare campaign against the commonly-used herbicide 2,4-D, whic...

Matching PubMed Articles

Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas. Although progress has been made in our understanding of the pathogenesis of the disease, no treatment targeting pat...

The management of Graves' disease in New Zealand 2014.

Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades. There is no 'gold-standard' treatment for GD.

Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.

The development of Graves' disease (GD) after subacute thyroiditis (SAT) is very rare and only a limited number of cases have been reported.

Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.

Graves' disease is an autoimmune thyroid disorder that mainly presents as hyperthyroidism and is caused by thyrotropin receptor antibodies (TRAbs) that stimulate thyroid-stimulating hormone receptors....

Thyroid surgery for Graves' disease and Graves' ophthalmopathy.

Graves' disease is an autoimmune disease caused by the production of auto-antibodies against the thyroid-stimulating hormone receptor, which stimulates follicular cell production of thyroid hormone. I...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement